Bliss GVS Pharma Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹256.99 crore, reflecting a quarter-on-quarter *(QoQ) increase of 17.75 per cent from ₹218.25 crore. This corresponds to a year-on-year *(YoY) growth of 29.80 per cent.
Operating Profit
Operating Profit stands at ₹44.44 crore, reflecting a quarter-on-quarter *(QoQ) increase of 37.71 per cent from ₹32.27 crore. This corresponds to a year-on-year *(YoY) growth of 110.72 per cent.
PBDT
PBDT stands at ₹53.62 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.87 per cent from ₹49.25 crore. This corresponds to a year-on-year *(YoY) growth of 70.33 per cent.
Profit Before Tax
Profit Before Tax stands at ₹44.95 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.90 per cent from ₹40.90 crore. This corresponds to a year-on-year *(YoY) growth of 91.77 per cent.
Net Profit
Net Profit stands at ₹37.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 49.31 per cent from ₹24.78 crore. This represents a 122.22 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Bliss GVS Pharma Ltd Earnings
- YOY
- QOQ
Bliss GVS Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Bliss GVS Pharma Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Bliss GVS Pharma Ltd Financial Reports
Bliss GVS Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Bliss GVS Pharma | -3.69% | 2.56% | 7.68% | 20.20% | 66.89% | 124.26% |
| IOL Chemicals | -3.12% | -2.67% | 16.19% | 41.79% | 13.16% | 30.17% |
| Dishman Carbogen | 9.50% | 6.35% | 15.21% | -0.94% | -21.69% | -10.28% |
| Novartis India | 1.42% | 2.19% | 21.56% | 46.41% | 47.29% | 36.23% |
| Gufic BioScience | -0.35% | -5.36% | -5.87% | -3.19% | -13.98% | -27.36% |
| Unichem Labs. | 1.88% | -2.49% | 5.94% | -0.34% | -22.11% | -38.42% |
| Hikal | -3.17% | -3.65% | 5.02% | -1.22% | -11.88% | -50.15% |
Company Info
Company Information
Whole-time Director : Vibha G Sharma
Whole-time Director : Shruti Vishal Rao
Non Executive & Independent Director : Santosh Parab
Company Sec. & Compli. Officer : Aditi Bhatt
Non Executive & Independent Director : Shilpa Bhatia
Managing Director : Gagan Harsh Sharmma
Chairman & Independent Director : Nandkumar Kashinath Chodankar
Managing Director & Chief Executive Officer : Shibroor N Kamath
Additional Director : VIJAYANARAYANAN
Additional Director : Deepak R Shah